New Orleans’ CityBusiness magazine recently posted an article that might be of interest to many of our clients and friends on the need to build your company with an eye toward potential exits. Mergers and acquisitions is one of our most active practice areas for exactly this reason. Great companies build their value with the future in mind! A solid understanding of the potential M&A strategies down the road is often important to a successful corporate financing strategy as well. Congratulations to the team at Bioceptive for the in-depth analysis they gave to the article and to the coverage Bioceptive received for their foresight. “Bioceptive, a biotechnology startup based in New Orleans, is barely three years off the ground. But its founders are already thinking of ways to attract the right investors to license or sell outright their top product, a device that aids health care workers with the insertion of intrauterine devices. …. Bioceptive CEO and President Stewart Davis said developing this exit strategy is integral to getting his company off the ground.  Nobody is going to invest in something they don’t think they can get their money out of,” Davis said. Bioceptive could try to raise the money needed to market and sell its product on their own, but Davis said it would also be costly. Taking a product through medical trials to test safety and efficiency is expensive, and it makes sense to license or sell the product to a larger company with the money to take it to market.”